Narcolepsy Therapeutics Market By Type ( Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy ), By Drug ( Central Nervous System Stimulants, Sodium Oxybate, Norepinephrine reuptake inhibitor (NRI), Tricyclic Antidepressants ), Industry Trends, Estimation & Forecast, 2017 - 2025

  • Published On: Apr, 2018
  • Category: Healthcare
  • Pages: 188
Narcolepsy Therapeutics Market is expected to grow with a CAGR of 6.1% during the forecast period of 2018 to 2025.

Market Overview:

Narcolepsy is neurological disorder that disrupts the sleep-wake cycle in humans, leading to excessive daytime sleepiness and loss of muscle strength. It is a long-term disorder that affects men and women equally and often commences from the childhood itself. Narcolepsy can be controlled with the help of certain therapeutic drugs, but no permanent cure has been discovered until now. Narcolepsy treatment is mainly carried out by the oral administration of the drugs; however, a change in the lifestyle of the patient has also proved to be effective in treating the disorder. The global narcolepsy therapeutics market is experiencing hurdles in its growth due to the symptomatic treatments used for treating the neurodegenerative disorder and the potential side effects of the therapeutics drugs administered by the patients. However, the increasing awareness among the global populace regarding narcolepsy and the advancements taking place in the healthcare industry are expected to fuel the growth of narcolepsy therapeutics market. In terms of region, North America is anticipated to lead the market, owing to the high prevalence of the disorder in the region. According to the data revealed by Narcolepsy Network, 1 in every 2000 people in the U.S. are affected by narcolepsy, i.e. 200,000 Americans. As per a certain research study, only 25% of the people affected with narcolepsy are diagnosed and treated, whereas, the rest 75% are left undiagnosed or misdiagnosed. Such notable percentage figure is anticipated to provide lucrative opportunities to the market players during the upcoming years, in correlation to the technological advancements occurring in the medical diagnosis. The report provides detailed qualitative and quantitative analysis of the narcolepsy therapeutics market. Market size and forecast in terms of value has been provided for the period - (2017 - 2025), for the segments namely type and drug in each of the major regions.

Narcolepsy Therapeutics Market Segmentation

By Type • Narcolepsy with Cataplexy • Narcolepsy without Cataplexy • Secondary Narcolepsy By Drug • Central Nervous System Stimulants • Sodium Oxybate • Norepinephrine reuptake inhibitor (NRI) • Tricyclic Antidepressants • Others By Geography • North America o U.S. o Canada o Mexico • Europe o U.K. o France o Germany o Italy o Spain o Rest of Europe • Asia-Pacific o China o Japan o India o Korea o Rest of APAC • South America o Brazil o Rest of South America • Rest of the World o Middle East o Africa

CHAPTER 1. INTRODUCTION 1.1. RESEARCH METHODOLOGY 1.1.1. ERC desk research 1.1.2. ERC data synthesis 1.1.3. Data validation and market feedback 1.1.4. ERC data sources CHAPTER 2. NARCOLEPSY THERAPEUTICS MARKET OVERVIEW 2.1. NARCOLEPSY THERAPEUTICS MARKET INTRODUCTION 2.2. GLOBAL NARCOLEPSY THERAPEUTICS MARKET PRODUCTION AND GROWTH RATE, 2017-2025 2.2.1. Global Narcolepsy Therapeutics Production (VOLUME) and Growth Rate (%), (2017-2025) 2.3. GLOBAL NARCOLEPSY THERAPEUTICS MARKET CAPACITY AND GROWTH RATE, 2017-2025 2.3.1. Global Narcolepsy Therapeutics Capacity (VOLUME) and Growth Rate (%), (2017-2025) 2.4. GLOBAL NARCOLEPSY THERAPEUTICS MARKET REVENUE AND GROWTH RATE, 2017-2025 2.4.1. Global Narcolepsy Therapeutics Market Revenue (Million USD) and Growth Rate (%), (2017-2025) 2.5. GLOBAL NARCOLEPSY THERAPEUTICS MARKET CONSUMPTION AND GROWTH RATE, 2017-2025 2.5.1. Global Narcolepsy Therapeutics Consumption (VOLUME) and Growth Rate (%), (2017-2025) 2.6. GLOBAL NARCOLEPSY THERAPEUTICS MARKET PRICE TREND, 2017-2025 2.6.1. Global Narcolepsy Therapeutics Market Price Trend (USD/ VOLUME) and Growth Rate (%), (2017-2025) CHAPTER 3. GLOBAL NARCOLEPSY THERAPEUTICS MARKET BY TYPE, 2017-2025 3.1. NARCOLEPSY WITH CATAPLEXY 3.2. NARCOLEPSY WITHOUT CATAPLEXY 3.3. SECONDARY NARCOLEPSY 3.4. GLOBAL NARCOLEPSY THERAPEUTICS MARKET REVENUE BY TYPE, 2017-2025 3.4.1. Global Narcolepsy Therapeutics Market Revenue (Million USD) and Share (%) By Type, 2017-2025 3.4.2. Narcolepsy with Cataplexy Market Revenue and Growth Rate, 2017-2025 3.4.3. Narcolepsy Without Cataplexy Market Revenue and Growth Rate, 2017-2025 3.4.4. Secondary Narcolepsy Market Revenue and Growth Rate, 2017-2025 26 3.5. GLOBAL NARCOLEPSY THERAPEUTICS MARKET PRODUCTION BY TYPE, 2017-2025 3.5.1. Global Narcolepsy Therapeutics Market Production (Volume) and Share (%) By Type, 2017-2025 3.5.2. Narcolepsy with Cataplexy Market Production and Growth Rate, 2017-2025 3.5.3. Narcolepsy Without Cataplexy Market Production and Growth Rate, 2017-2025 3.5.4. Secondary Narcolepsy Market Production and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for other type segment. CHAPTER 4. GLOBAL NARCOLEPSY THERAPEUTICS MARKET BY DRUG, 2017-2025 4.1. CENTRAL NERVOUS SYSTEM STIMULANTS 4.2. SODIUM OXYBATE 4.3. NOREPINEPHRINE REUPTAKE INHIBITOR (NRI) 4.4. GLOBAL NARCOLEPSY THERAPEUTICS MARKET REVENUE BY DRUG, 2017-2025 4.4.1. Global Narcolepsy Therapeutics Market Revenue (Million USD) and Share (%) By Drug, 2017-2025 4.4.2. Central Nervous System Stimulants Market Revenue and Growth Rate, 2017-2025 4.4.3. Sodium Oxybate Market Revenue and Growth Rate, 2017-2025 4.4.4. Norepinephrine reuptake inhibitor (NRI) Market Revenue and Growth Rate, 2017-2025 4.5. GLOBAL NARCOLEPSY THERAPEUTICS MARKET CONSUMPTION BY DRUG, 2017-2025 4.5.1. Global Narcolepsy Therapeutics Market Consumption (Volume) and share (%) By Drug, 2017-2025 4.5.2. Central Nervous System Stimulants Market Consumption and Growth Rate, 2017-2025 4.5.3. Sodium Oxybate Market Consumption and Growth Rate, 2017-2025 4.5.4. Norepinephrine reuptake inhibitor (NRI) Market Consumption and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for other drug segment. CHAPTER 5. GLOBAL NARCOLEPSY THERAPEUTICS MARKET BY REGION, 2017-2025 5.1. NORTH AMERICA 5.1.1. U.S. 5.1.2. Canada 5.1.3. Mexico 5.2. EUROPE 5.2.1. U.K. 5.2.2. France 5.2.3. Germany 5.2.4. Italy 5.2.5. Spain 5.2.6. Rest of Europe 5.3. ASIA PACIFIC 5.3.1. China 5.3.2. Japan 5.3.3. India 5.3.4. Korea 5.3.5. Rest of APAC 5.4. SOUTH AMERICA 5.4.1. Brazil 5.4.2. Rest of South America 5.5. REST OF THE WORLD 5.5.1. Middle East 5.5.2. Africa 5.6. GLOBAL NARCOLEPSY THERAPEUTICS MARKET REVENUE BY REGION, 2017-2025 5.6.1. Global Narcolepsy Therapeutics Market Revenue (Million USD) and Share (%) By Region, 2017-2025 5.6.2. North America Market Revenue and Growth Rate, 2017-2025 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025 5.6.5. South America Market Revenue and Growth Rate, 2017-2025 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025 CHAPTER 6. GLOBAL NARCOLEPSY THERAPEUTICS MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025 6.1. GLOBAL NARCOLEPSY THERAPEUTICS MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025 6.1.1. Global Narcolepsy Therapeutics Market Production (Volume) and Share (%) By Region, 2017-2025 6.1.2. Global Narcolepsy Therapeutics Market Consumption (Volume) and Share (%) By Region, 2017-2025 6.1.3. North America Market Production and Consumption, 2017-2025 6.1.4. Europe Market Production and Consumption, 2017-2025 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025 6.1.6. South America Market Production and Consumption, 2017-2025 6.1.7. Rest of the World Market Production and Consumption, 2017-2025 CHAPTER 7. MARKET DETERMINANTS 7.1. MARKET DRIVERS 7.2. MARKET RESTRAINTS 7.3. MARKET OPPORTUNITIES 7.4. MARKET DETERMINANTS RADAR CHART CHAPTER 8. GLOBAL NARCOLEPSY THERAPEUTICS MARKET COMPETITION BY MANUFACTURERS 8.1. GLOBAL NARCOLEPSY THERAPEUTICS PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025) 8.1.1. Global Narcolepsy Therapeutics Production (VOLUME) and Share (%) by Manufacturers (2017-2025) 8.2. GLOBAL NARCOLEPSY THERAPEUTICS REVENUE AND SHARE BY MANUFACTURERS (2017-2025) 8.2.1. Global Narcolepsy Therapeutics Revenue (Million USD) and Share (%) by Manufacturers (2017-2025) 8.3. NARCOLEPSY THERAPEUTICS MARKET COMPETITIVE SITUATION AND TRENDS 8.3.1. Narcolepsy Therapeutics Market Share (%) of Top 3 Manufacturers 8.3.2. Narcolepsy Therapeutics Market Share (%) of Top 5 Manufacturers CHAPTER 9. GLOBAL NARCOLEPSY THERAPEUTICS MANUFACTURERS ANALYSIS 9.1. JAZZ PHARMACEUTICALS PLC 9.1.1. Business Overview 9.1.2. Company Basic Information 9.1.3. Narcolepsy Therapeutics Product Details 9.1.4. Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Production, Revenue and Gross Margin 9.2. TEVA PHARMACEUTICAL INDUSTRIES LTD. 9.2.1. Business Overview 9.2.2. Company Basic Information 9.2.3. Narcolepsy Therapeutics Product Details 9.2.4. Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Production, Revenue and Gross Margin 9.3. SHIRE 9.3.1. Business Overview 9.3.2. Company Basic Information 9.3.3. Narcolepsy Therapeutics Product Details 9.3.4. Shire Narcolepsy Therapeutics Production, Revenue and Gross Margin 9.4. LIGAND PHARMACEUTICALS INC. 9.4.1. Business Overview 9.4.2. Company Basic Information 9.4.3. Narcolepsy Therapeutics Product Details 9.4.4. Ligand Pharmaceuticals Inc. Narcolepsy Therapeutics Production, Revenue and Gross Margin 9.5. GRAYMARK HEALTHCARE INC. 9.5.1. Business Overview 9.5.2. Company Basic Information 9.5.3. Narcolepsy Therapeutics Product Details 9.5.4. Graymark Healthcare Inc. Narcolepsy Therapeutics Production, Revenue and Gross Margin 9.6. ADDRENEX PHARMACEUTICALS INC. 9.6.1. Business Overview 9.6.2. Company Basic Information 9.6.3. Narcolepsy Therapeutics Product Details 9.6.4. Addrenex Pharmaceuticals Inc. Narcolepsy Therapeutics Production, Revenue and Gross Margin 9.7. BIOPROJET 9.7.1. Business Overview 9.7.2. Company Basic Information 9.7.3. Narcolepsy Therapeutics Product Details 9.7.4. BIOPROJET Narcolepsy Therapeutics Production, Revenue and Gross Margin CHAPTER 10. NARCOLEPSY THERAPEUTICS MARKET VALUE CHAIN ANALYSIS 10.1. NARCOLEPSY THERAPEUTICS INDUSTRIAL CHAIN ANALYSIS 10.2. NARCOLEPSY THERAPEUTICS KEY RAW MATERIALS ANALYSIS 10.2.1. Key Raw Materials 10.2.2. Price Trend of Key Raw Materials 10.2.3. Key Suppliers of Raw Materials 10.3. CONSUMER ANALYSIS 10.3.1. Consumer 1 10.3.2. Consumer 2 10.3.3. Consumer 3 10.3.4. Consumer 4

• Jazz Pharmaceuticals PLC
• Teva Pharmaceutical Industries Ltd.
• Shire
• Ligand Pharmaceuticals Inc.
• Graymark Healthcare Inc.
• Addrenex Pharmaceuticals Inc.
• BIOPROJET

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS